WO2017116608A2 - Devices, methods, and compositions for restricting cell position and stabilizing cells in culture systems - Google Patents

Devices, methods, and compositions for restricting cell position and stabilizing cells in culture systems Download PDF

Info

Publication number
WO2017116608A2
WO2017116608A2 PCT/US2016/064647 US2016064647W WO2017116608A2 WO 2017116608 A2 WO2017116608 A2 WO 2017116608A2 US 2016064647 W US2016064647 W US 2016064647W WO 2017116608 A2 WO2017116608 A2 WO 2017116608A2
Authority
WO
WIPO (PCT)
Prior art keywords
cells
gel
microfluidic
chamber
membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2016/064647
Other languages
French (fr)
Other versions
WO2017116608A3 (en
Inventor
Kambez HAJIPOURAN BENAM
Richard Novak
Donald E. Ingber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard University
Original Assignee
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard University filed Critical Harvard University
Priority to CA3007084A priority Critical patent/CA3007084A1/en
Priority to US15/781,080 priority patent/US20200263118A1/en
Priority to AU2016382614A priority patent/AU2016382614A1/en
Priority to SG11201804575QA priority patent/SG11201804575QA/en
Priority to GB1810996.7A priority patent/GB2562920B/en
Publication of WO2017116608A2 publication Critical patent/WO2017116608A2/en
Publication of WO2017116608A3 publication Critical patent/WO2017116608A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/02—Membranes; Filters
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
    • A01N1/142—Apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/16—Microfluidic devices; Capillary tubes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/14—Scaffolds; Matrices
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0006—Modification of the membrane of cells, e.g. cell decoration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0688—Cells from the lungs or the respiratory tract
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/10—Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers

Definitions

  • the present invention relates generally to simulation of a tissue function, and, more particularly, to preventing cell invasion in a microfluidic device.
  • Human endothelial cells have lengths and widths on the micron scale, e.g., in the 5-25 micron (“ ⁇ ") range, when flattened within monolayers in vitro, when lining the vasculature, or within engineered organs-on-chips that mimic in vivo tissue and organ architecture. Additional details in reference to the scale of human endothelial cells are described in "Image Analysis of Endothelial Microstructure and Endothelial Cell Dimensions of Human Arteries - A Preliminary Study," by Bora Garipcan et al., published online on December 10, 2010 (DOI: 10.1002/adem.201080076), which is incorporated herein by reference in its entirety.
  • undesired cell migration occurs through the pores and interferes with plating or growth of neighboring tissues, whose presence is required to create critical tissue-tissue interfaces that mimic organ architecture with endothelial cells.
  • This problem can occur when pores are greater than ⁇ 1 ⁇ in diameter.
  • HUVECs human umbilical vein endothelial cells
  • cells can escape from a seeded channel to an opposite channel within 1- 3 days of cell seeding.
  • the microfluidic device includes two polydimethylsiloxane (“PDMS”) top and bottom slabs sandwiching a porous polyethylene terephthalate (“PET”) or polycarbonate membrane containing 5 ⁇ pores to create a top and a bottom channel.
  • PDMS polydimethylsiloxane
  • PET polyethylene terephthalate
  • polycarbonate membrane containing 5 ⁇ pores to create a top and a bottom channel.
  • This type of cell migration can lead to experimental failures.
  • cell escape occurs when using membranes with 3 ⁇ or 8 ⁇ pores.
  • a device includes a first structure defining a first chamber, the first chamber including cells adhered thereon, and the first chamber further including a stimulus-responsive polymer gel on top of the cells.
  • the device is a microfluidic device, and the first chamber includes a first microfluidic channel.
  • the microfluidic device further includes a second microfluidic channel in fluidic communication with the first microfluidic channel.
  • the first chamber includes an agent that is blocked from contacting the cells by the gel.
  • the agent is a drug.
  • the agent is a growth factor.
  • the gel prevents the cells from differentiating.
  • the device is housed in a storage container.
  • the gel is fluid permeable.
  • the gel is water impermeable.
  • the device further includes a porous membrane located at an interface region between the first microfluidic channel and the second microfluidic channel, the membrane having a first side and a second side the cells being adhered on the first side.
  • the stimulus- responsive polymer gel is capable of being dissolved by exposure to an external stimulus.
  • the external stimulus is selected from a group consisting of temperature, light, pH, a small molecule, an enzyme and a combination of two or more thereof.
  • the fluid- permeable, stimulus-responsive polymer gel is selected from a group consisting of Pluronic F127, Pluronic F68, poly(N-isopropylacrylamide), alginates, and a combination of two or more thereof.
  • each of the microfluidic channels is in fluidic communication with ports.
  • a device includes a first structure defining a first chamber, a second structure defining a second chamber; and a porous membrane located at an interface region between the first chamber and the second chamber.
  • the membrane has a first side facing toward the first chamber and a second side facing toward the second chamber, the membrane separating the first chamber from the second chamber.
  • the first side includes cells adhered thereto, the second side including a stimulus-responsive polymer gel thereon.
  • the first chamber is in the form of a first microchannel and the second chamber is in the form of a second microchannel.
  • the first chamber is a top chamber located above the porous membrane and the second chamber is a bottom chamber located below the porous membrane.
  • the second chamber is filled with the stimulus-responsive polymer gel.
  • the stimulus- responsive polymer gel is removable in response to an external stimulus.
  • the gel is fluid permeable.
  • the gel is water impermeable.
  • the cells include primary human airway epithelial cells.
  • the fluid- permeable, stimulus-responsive polymer gel is selected from a group consisting of Pluronic F127, Pluronic F68, poly(N-isopropylacrylamide), alginates, and a combination of two or more thereof.
  • a method is directed to preventing cell differentiation, and includes a) seeding viable cells on to a surface of a device under conditions such that at least a portion adheres thereon. The method also includes b) introducing a stimulus-responsive polymer gel on top of the cells under conditions such that differentiation of the cells is prevented and the cells remain viable.
  • the device is a Transwell device.
  • the device is a microfluidic device.
  • the microfluidic device includes a first microfluidic channel in fluidic communication with a second microfluidic channel.
  • the first microfluidic channel is separated from the second microfluidic channel by a porous membrane, the membrane having a first surface and a second surface.
  • the cells are adhered to the first surface of the membrane and the gel covers the adhered cells.
  • the method further includes c) feeding the cells with nutrients through the second surface of the membrane while the cells are covered on the first surface by the gel.
  • the cells are airway epithelial cells and the gel blocks the cells from air exposure, thereby preventing differentiation of the airway epithelial cells.
  • the method further includes d) removing the gel so that the cells are not prevented from differentiating.
  • a method is directed to preserving cells for storage or shipment, and includes a) seeding viable cells on to a surface of a device under conditions such that at least a portion adhere thereon. The method further includes b) introducing a stimulus-responsive polymer gel on top of the cells under conditions such the adhered cells remain viable, thereby preserving the cells.
  • the method further includes
  • the method further includes c) storing the cells.
  • the device is a Transwell device.
  • the device is a microfluidic device.
  • the microfluidic device includes a first microfluidic channel in fluidic communication with a second microfluidic channel.
  • the first microfluidic channel is separated from the second microfluidic channel by a porous membrane, the membrane having a first surface and a second surface.
  • the cells are adhered to the first surface of the membrane and the gel covers the adhered cells.
  • the method further includes c) removing the gel so that the cells are not covered by the gel.
  • a method is directed to restricting the position of cells in a microfluidic device, the device including a first region and a second region. The method includes polymerizing a biopolymer material in the first region, seeding cells such that they attach to the second region but are prevented from attaching to the first region by the polymerized material, and after the seeding, depolymerizing and removing the biopolymer material from the first region.
  • the first region and second region are separated by a porous membrane, the porous membrane having top and bottom surfaces.
  • the method further includes imaging cell migration across the porous membrane.
  • the depolymerizing is in response to applying an external stimulus.
  • the external stimulus is one or more of a temperature application, a light application, a pH application, an enzyme application and a small molecule application.
  • the polymerizing of the biopolymer material includes incubation at a temperature of approximately 37 °Celsius for approximately 30 minutes, the biopolymer material being a Pluronic F127 biopolymer.
  • the incubation results in a solidified material that blocks cell contact with the first region.
  • the first region includes a top microfluidic compartment selected from the group consisting of a microfluidic chamber or microfluidic channel.
  • the second region includes a bottom microfluidic compartment selected from the group consisting of a microfluidic chamber or microfluidic channel.
  • the first region includes a top surface of a membrane, or portion thereof.
  • the first region includes a bottom surface of a membrane, or portion thereof.
  • the microfluidic device is an organ-on-chip device.
  • the method further including seeding cells in the first region.
  • the cells in the first region are different from the cells in the second region.
  • a method is directed to restricting the position of cells in a microfluidic device, the device including a top compartment and a bottom compartment separated by a porous membrane.
  • the method includes a) forming a gel in the top or bottom compartment or membrane, or portion thereof, and b) seeding cells on a region of the top or bottom compartments or membrane that is not blocked by the gel, thereby restricting the position of the cells in the microfluidic device.
  • the method further includes c) removing the gel from the microfluidic device.
  • the gel is removed by a method comprising depolymerizing the gel in response to applying an external stimulus.
  • the external stimulus is one or more of a temperature application, a light application, a pH application, an enzyme application and a small molecule application.
  • the forming of the gel in step a) includes polymerizing a biopolymer material.
  • the polymerizing of the biopolymer material includes incubation at a temperature of approximately 37 °Celsius for approximately 30 minutes, the biopolymer material being a Pluronic F127 biopolymer.
  • the incubation results in a solidified material that blocks contact with the cells in a region of the microfluidic device.
  • the top microfluidic compartment is selected from the group consisting of a microfluidic chamber or microfluidic channel.
  • the bottom microfluidic compartment is selected from the group consisting of a microfluidic chamber or microfluidic channel.
  • the microfluidic device is an organ-on-chip device or a Transwell device.
  • the microfluidic device further includes ports in fluid communication with the top and bottom compartments and the seeding comprises introducing cells into the ports in a flow of culture media.
  • a method is directed to restricting the position of cells in a microfluidic device, the device including a porous membrane, the porous membrane including i) pores and ii) first and second sides.
  • the method includes a) forming a gel in the first or second side of the membrane, or portion thereof, and b) seeding cells on a region of the membrane on the side opposite to the side including the gel under conditions such that the cells are prevented by the gel from moving through the pores, thereby restricting the position of the cells in the microfluidic device.
  • the method further includes c) removing the gel from the microfluidic device.
  • the gel is a water impermeable gel.
  • the gel is a calcium alginate gel and the gel is removed by washing out or chelating the calcium in the calcium alginate gel.
  • the microfluidic device is an organ-on-chip device or a Transwell device.
  • the gel is a collagen gel and the collagen gel is removed with an enzyme.
  • FIG. 1A is an exploded perspective view illustrating a device for simulating a function of a tissue, in accordance with one embodiment.
  • FIG. IB is an assembled perspective view of the device shown in FIG. 1 A.
  • FIG. 2A is a perspective view illustrating a device for simulating a function of a tissue, in accordance with another embodiment.
  • FIG. 2B shows the device of FIG. 2A with a biopolymer-filled bottom microchannel.
  • FIG. 2C shows the device of FIG. 2B with a cell-seeded top microchannel.
  • FIG. 2D shows the device of FIG. 2C with the biopolymer removed from the bottom microchannel.
  • FIG. 2E shows the device of FIG. 2D with a cell layer seeded in the bottom microchannel.
  • FIG. 3A shows a perspective view of an organ-on-chip (OOC) device, in accordance with yet another embodiment.
  • OOC organ-on-chip
  • FIG. 3B shows an exploded perspective view of the OOC device of FIG. 3 A.
  • FIG. 3C shows a cutaway perspective view with enlarged features of the OOC device of FIG. 3B.
  • FIG. 3D shows a cutaway side view with enlarged features of the OOC device of FIG. 3C.
  • FIG. 4 illustrates a system, in accordance with yet another embodiment, in which cells are seeded on top of a porous membrane.
  • FIG. 5 illustrates a system, in accordance with yet another embodiment, in which cells are submerged underneath a biopolymer.
  • FIG. 6A illustrates a TRANSWELL® insert system, in accordance with yet another embodiment.
  • FIG. 6B illustrates a biopolymer inserted in a bottom compartment of the system of FIG. 6 A.
  • FIG. 6C illustrates cells seeded in a top compartment of the system of FIG. 6A.
  • FIG. 7A illustrates a TRANSWELL® insert system, in accordance with yet another embodiment.
  • FIG. 7B illustrates a biopolymer inserted in a top compartment of the system of FIG. 7A.
  • FIG. 7C illustrates cells seeded in a bottom compartment of the system of FIG. 7A.
  • FIG. 7D illustrates the biopolymer removed from the top compartment of the system of FIG. 7A.
  • FIG. 7E illustrates another cell type added to the top compartment of the system of FIG. 7 A.
  • FIG. 7F illustrates a migration assay in the system of FIG. 7A.
  • FIG. 8 shows a timeline illustrating effects of delaying differentiation of cells.
  • FIG. 9A shows a microscopic image of epithelial morphology in a sample without polymer exposure.
  • FIG. 9B shows a microscopic image of epithelial morphology in a sample with polymer exposure.
  • microfluidic as used herein relates to components where moving fluid is constrained in or directed through one or more chambers or channels wherein one or more dimensions are 1 millimeter (“mm") or smaller (microscale).
  • Microfluidic channels may be larger than microscale in one or more directions, though the channel(s) will be on the microscale in at least one direction.
  • the geometry of a microfluidic channel may be configured to control the fluid flow rate through the channel (e.g. increase channel height to reduce shear).
  • Microfluidic channels can be formed of various geometries to facilitate a wide range of flow rates through the channels.
  • Microfluidic devices include (but are not limited to) organ-on-chip devices and Transwell devices.
  • Channels are pathways (whether straight, curved, single, multiple, in a network, etc.) through a medium (e.g., silicon) that allow for movement of liquids and gasses. Channels, thus, can connect other components, i.e., keep components “in communication” and more particularly, “in fluidic communication,” and still more particularly, “in liquid communication.” Such components include, but are not limited to, liquid-intake ports and gas vents. Microchannels are channels with dimensions less than 1 mm and greater than 1 micron.
  • channels in a microfluidic device are in fluidic communication with cells and (optionally) a fluid source such as a fluid reservoir.
  • a fluid source such as a fluid reservoir.
  • Two components may be coupled to each other even though they are not in direct contact with each other.
  • two components may be coupled to each other through an intermediate component (e.g., tubing or other conduit).
  • undesirable cell migration is prevented when the migration occurs through a membrane with a pore size greater than 1 ⁇ in diameter and when cells (such as endothelial cells) are cultured thereon in a microfluidic device, such as an organ-on-chip (“OOC”) device.
  • OOC organ-on-chip
  • an approach includes seeding cells in the first microchannel of a microfluidic cell culture device (e.g., the OOC device) while the second opposite microchannel has a stimulus-responsive biocompatible polymer.
  • the biocompatible polymer Upon exposure to a first stimulus, the biocompatible polymer forms a gel to prevent cell invasion.
  • the gel is readily dissolved or removed upon exposure to a second stimulus, when it is desired to plate another cell type in the second opposite microchannel.
  • the gel includes a collagen type of gel, a water impermeable type of gel, and/or other types of gels.
  • an exemplary of a microfluidic device 100 is in the form of an OOC device that includes a top slab 102 separated from a bottom slab 104 by a porous membrane 106.
  • the top slab 102 defines a first chamber 108 (which is illustrated in the form of a top microchannel), and the second slab 104 defines a second chamber 110 (which is illustrated in the form of a bottom microchannel).
  • the porous membrane 106 is located at an interface region between the first chamber 108 and the second chamber 110, separating the two chambers 108, 110, and has a first side 112 facing toward the first chamber 108 and a second side 114 facing toward the second chamber 110.
  • a first fluid inlet 116 is provided for fluid flow into the top microchannel 108
  • a second fluid inlet 118 is provided for fluid flow into the bottom microchannel 110.
  • the culturing and prevention of undesirable cell migration is achieved, for example, in micro-, meso-, and/or macro-fluidic settings.
  • the microfluidic device 100 is provided with the top and bottom microchannels 108, 110 empty (e.g., lacking any fluids, cultured cells, or gels).
  • the bottom microchannel 110 is temporally or temporarily filled with a biocompatible polymer gel 120 to prevent cell invasion.
  • the top microchannel 108 is seeded with one or more cell layers 122.
  • the polymer gel 120 is removed from the bottom microchannel 110.
  • the polymer gel 120 is removed with enzymes.
  • the removal of the polymer gel 120 typically occurs when a user desires to plant another cell type in the bottom microchannel 110.
  • the bottom microchannel 110 is seeded with one or more cell layers 124 (e.g., a blood-brain barrier or epithelial-endothelial co-culture systems).
  • an OOC device 200 that includes a body 201 with an upper body segment 202 and a lower body segment 204.
  • the upper body segment 202 and the lower body segment 204 are preferably made of a polymeric material, such as PDMS, PMMA, polycarbonate, COP/CoC, polyurethane, or SBS/SEBS.
  • the OOC device 200 includes a porous membrane 206 that is located at an interface region between the upper body segment 202 and the lower body segment 204, separating a top microchannel 208 from a bottom microchannel 210.
  • the membrane 206 has a first side 212 facing toward the top microchannel 208 and a second side 214 facing toward the bottom microchannel 210.
  • a first fluid inlet 216 is provided for fluid flow into the top microchannel 208, and a second fluid inlet 218 is provided for fluid flow into the bottom microchannel 210.
  • a first fluid outlet 217 is provided for fluid flow exiting the top microchannel 208
  • a second fluid outlet 219 is provided for fluid flow exiting the bottom microchannel 210.
  • the OOC device 200 includes one or more additional top and bottom microchannels, such as cross-flow microchannels 221, 222, with respective third fluid inlet and outlet 223, 224.
  • the membrane 206 includes a plurality of pores 226 through which cells are able to migrate between the top microchannel 208 and the bottom microchannel 210.
  • the size of the pores 226 is selected in accordance with achieving a desired migration, simulating a specific function in vitro.
  • the top microchannel 208 is filled at least in part with a biocompatible polymer gel 220, which is attached to the top surface 212 of the membrane 206.
  • the bottom microchannel 210 includes a cell layer 222, which is seeded onto the bottom surface 214 of the membrane 206. While the polymer gel 220 is in place on the top surface 221 of the membrane 206, the polymer gel 220 prevents undesired or inadvertent migration of cells 222 from the bottom microchannel 210 into the top microchannel 208. When migration of cells 222 is desired, the polymer gel 220 is removed at least in part from the top microchannel 208.
  • a microfluidic device 300 includes a top microchannel 308, a porous membrane 306, and a bottom microchannel 310.
  • the microfluidic device 300 including one or more of its features, is similar to or identical to the microfluidic device 100 illustrated in FIGs. 1A and IB.
  • the microfluidic device 300 includes one or more features of a TRANSWELL® insert system 309, for a static cell culture.
  • the microfluidic device 300 includes primary human airway epithelial cells 322 that are seeded on top of the porous membrane 306, within the top microchannel 308. Additionally, the microfluidic device 300 includes a cell culture medium 323 in the bottom microchannel 310. Referring specifically to FIG. 5, the cells 322 are submerged underneath underneath a biopolymer gel 320. The cells 322 are kept submerged under the polymer without disrupting cell monolayer quality and the cell ability to differentiate in vitro. This aspect is helpful in serving at least two purposes: (1) to delay differentiation of desired cell type, and (2) to preserve and stabilize live cell layers 322 submerged under biopolymer gel 320 for shipment of OOC devices or for reducing the total amount of medium required.
  • the microfluidic device 300 is beneficial in stabilizing cell cultures or replacing cell culture medium in cell-containing platforms for maintenance or shipment from one location to another. For example, by filling a microchannel with a biopolymer gel 320, the total amount of cell culture medium required is reduced.
  • a microfluidic device 400 includes similar or identical features to the TRANSWELL® insert system 309 illustrated in FIGs. 4 and 5.
  • the microfluidic device 400 includes a top compartment 408 (e.g., an insert), a porous membrane 406, and a bottom compartment 410 (e.g., a well).
  • a biopolymer gel 420 is polymerized in the bottom compartment 410.
  • cells 422 are seeded on top of the membrane 406, in the top compartment 408.
  • This approach is useful, for example, for assays such as immune cell chemotaxis assays in which a single endothelial layer is required on large-pore (e.g. 3-8 ⁇ ) membrane.
  • the microfluidic device 400 and the biopolymer gel 420 are incubated under a condition that maintains the biopolymer gel 420 in a liquid form.
  • the microfluidic device and a biocompatible polymer Pluronic F127 are incubated at about 4° C for about 30 minutes. The procedure is performed while the top compartment 408 (reserved for cell seeding) is clamped or blocked on both ends to prevent polymer leak. This step is carried out quickly, and, then, the polymer-filled microdevice is placed at a temperature selected for allowing the polymer to gel.
  • the polymer-filled microdevice is placed in a 37° C incubator for about 15 min to allow the biopolymer gel 420 to transition from liquid form to gel form.
  • a suspension of cells 422 e.g., endothelial cells such as human umbilical vein endothelial cells ("HUVECs")
  • UUVECs human umbilical vein endothelial cells
  • a culture medium of the cell-seeded compartment 408 is replaced with a fresh medium, e.g., by connecting the microfluidic device 400 to microfluidic flow.
  • the microfluidic device 400 is continuously monitored for any sign of cell escape into the polymer-filled compartment 410.
  • a microfluidic device 500 includes similar or identical features to the TRANSWELL® insert system 309 illustrated in FIGs. 4 and 5.
  • the microfluidic device 500 includes a top compartment 508, a porous membrane 506, and a bottom compartment 510.
  • a biopolymer gel 520 is polymerized in the top compartment 508.
  • a first type of cells 522 is seeded on the undersurface of the membrane 506, in the bottom compartment 510.
  • the biopolymer gel 520 is depolymerized and removed from the top compartment 508.
  • a second type of cells 525 is added to the top compartment 508.
  • a migration assay is performed to analyze (e.g., image) migration of one or more cells 523 of the first type of cells 522 that migrate through the membrane 506, from the bottom compartment 510 to the top compartment 508.
  • a timeline illustrates delaying differentiation of cells in vitro without causing adverse effects on cell behavior and/or quality.
  • the delaying of the cellular differentiation is for a desired period of time, e.g., for a number of days or a number of hours.
  • cells are fed with nutrients and kept alive through one side (e.g., basal side) while the other side of the cells (e.g., apical side) is exposed to the biopolymer gel.
  • one side e.g., basal side
  • the other side of the cells e.g., apical side
  • air exposure is a known inducer of cellular differentiation for cells like airway epithelial cells.
  • submerging the cells apically with polymer delays differentiation as long as a user intends.
  • a first set of epithelial cells serves as a control group of samples (e.g., confluent epithelial monolayers) that are not exposed to a biopolymer gel.
  • the first set of epithelial cells are directly taken to an air-liquid interface ("ALI") 24 days prior to the microscopic observation of cell monolayer and cilia beating.
  • ALI is a key driver of airway epithelial cell differentiation into ciliated cells.
  • a replacement of an apical medium with the biopolymer gel is also performed 24 days prior to the microscopic observation.
  • Confluent human airway epithelial cells are submerged under the biopolymer gel for 7 days within a microfluidic device (e.g., an OOC device as described above).
  • a microfluidic device e.g., an OOC device as described above.
  • the ALI induction is performed, later, only 17 days prior to the microscopic observation.
  • differentiation is achieved by removing the biopolymer gel and introducing air into the microchannel to form the ALI.
  • no adverse effects re observed in cell behavior and/or quality between the first set of epithelial cells and the second set of epithelial cells.
  • FIGs. 9A and 9B sample microscopic images illustrate similar results in both sets of epithelial cells discussed above in reference to FIG. 8.
  • a phase-contrast microscopic image shows the first set of cells, which has not been exposed to the biopolymer gel, on day 24 (post-ALI) with a nice cobblestone packed epithelial morphology.
  • a phase- contrast microscopic images shows the second set of cells, which has been exposed to the biopolymer gel, on day 17 (post-ALI) with a similar nice cobblestone packed epithelial morphology.
  • Cilia beating (10X slowed down) was measured for both sets of cells, with good and comparable measures in both sets of cells.
  • the cells that are overlaid with the biopolymer gel not only have a normal cobblestone packed epithelial monolayer (by benchmarking against and similar to polymer- untreated cells), but also exhibit an ability to differentiate into ciliated epithelium.
  • the cell differentiation is delayed compared to the control cultures by approximately the number of days that the cells are kept covered with the polymer and held in a "suspended state.” This indicates that the cells are stabilized biologically by the biopolymer gel described herein to avoid unwanted differentiation, or potentially de-differentiation, during transport or long-term tissue maintenance.
  • the extremely high viscosity of the gelled polymer prevents shear-induced damage to the tissue during transport and handling.
  • This aspect is beneficial at least for shipping organs, tissues, or cells in a microfluidic device when they can be cultured in a suspended state.
  • the user Upon receipt of the microfluidic device, the user removes the polymer, adds medium (or air), and reboots the differentiation process necessary to complete a desired study.
  • biocompatible polymer gels for use in reference to any of the gels discussed above, include, but are not limited to the following:
  • PNIPAAm Poly(N-isopropylacrylamide)
  • Alginates which gels in the presence of calcium but dissolves when calcium chelators are added.
  • Pluronic F127 prevents endothelial cell escape and invasion into a second microchannel of an organ chip in an in vitro assay.
  • Pluronic F127 is a triblock co-polymer that exhibits a reverse thermal gelling behavior in which, unlike most gels (e.g., agarose, gelatin, etc.), it solidifies at high temperatures (e.g., >20° C) and melts at low temperatures (e.g., ⁇ 4° C). This behavior is applicable in many biomedical applications, such as areas of tissue engineering, drug delivery, and controlled compound release into tissue. Additional details regarding Pluronic F127 are described in "Applications of Thermo-Reversible Pluronic F-127 Gels in Pharmaceutical Formulations," by J. J.
  • Pluronic F68 a similar behavior to Pluronic F127. Additional details regarding Pluronic F68 are described in "Rheological Properties of Thermo-Responsive Microemulsion-based Gels Formed by Pluronic F68," by Zhao et al. (J. Chem. Pharm. Res., 2014, 6(7): 2067-2072), which is incorporated herein by reference in its entirety.
  • Other polymers include any other polymer or materials with the ability to polymerize and depolymerize in a range of about 0-37° C. Such polymers or materials do not interfere with cell adhesion, growth, or differentiation (depending on the tested cell).
  • the biocompatible polymer is Pluronic F127 having 1-50% weight/volume ("w/v"), 15-30% w/v, or 25% w/v.
  • the PNIPAAm polymer provides the ability to be washed out of a microchannel of a microfluidic cell culture device (e.g., an organ chip) when cells (e.g., a different types of cells) are desired to be seeded in the microchannel.
  • a microfluidic cell culture device e.g., an organ chip
  • cells e.g., a different types of cells
  • Alginates can also be used which can be gelled with calcium and dissolved with calcium chelators.
  • a low viscosity of the biocompatible polymer is at about 4° C allows filling or emptying of very small microchannels and other features without affecting cells or devices due to pressure and shear.
  • biocompatible polymers described herein are optically transparent and non- fluorescent in typical imaging wavelengths, unlike some other thermally-responsive gels (e.g. PNIPAAm).
  • the stimulus responsive biocompatible polymer gels are optionally or alternatively overlaid on top of a cultured cell monolayer.
  • This approach delays initiation of a certain cell process (such as cell differentiation) until the organ chip is ready to use, and/or to protect submerged live cell layers from shear-induced damage during transport and handling.
  • the biocompatible polymer gel is optionally selected from polymers that offer one or more of the following characteristics: (1) biocompatibility such that the biocompatible polymer gel does not interfere with culture, growth, and potentially differentiation of seeded cells; (2) the polymer gel does not readily leak into or block a cell- containing microchannel; and (3) the first microchannel is polymerized and de-polymerized using one or more stimuli that have minimal or no cytotoxicity or significant biological effects.
  • a change in temperature at an approximate range of 4° - 37° C is typically well-tolerated by many cells, but a large change in pH can have detrimental impact on the cells and cause cytotoxicity or cellular stress.
  • the biocompatible polymer gel is nonbiodegradable.
  • the biocompatible polymer gel does not include any extracellular matrix proteins that degrade by cells or that affect cell growth and/or functions.
  • a device for mechanical actuation or stimulation of the tissue without affecting the blocking polymer gel.
  • cell-compatible reversal and polymer removal processes avoid harsh chemical, ultraviolet ("UV"), and/or thermal treatments.
  • UV ultraviolet
  • the methods described herein are simple, fast, and sterile process-compatible methods.
  • biocompatible polymers can also be utilized to stabilize cell cultures in culture devices.
  • biocompatible polymers protect cells against movement-induced fluid shear forces and/or minimize the total amount of medium requirements.
  • the protection and/or minimization features are beneficial for shipping or storage of tissues, organs, or cells in a microfluidic cell culture device (e.g., an organ chip) in a way that optimizes the respective structure and function.
  • the biocompatible polymer transitions between liquid and gel states at about 25° C for 25% w/v solutions.
  • This biocompatible polymer enables removal at a cell-compatible temperature, such as 4° C.
  • the biocompatible polymer is also optically clear and is non-autofluorescent, allowing the biocompatible polymer to be used without interfering with imaging applications.
  • the biocompatible polymer does not prevent or negatively influence cell attachment and growth in a culture. For example, a monolayer becomes evident on day two of post seeding in a gel -free microchannel.
  • the cell layer morphology is comparable to the morphology in chips that are seeded without polymer in the opposite microchannel. Importantly, no cell escape occurs to the unseeded microchannel.
  • the biocompatible polymer undergoes polymerization-de-polymerization via a method other than one having a temperature change, as long as the method does not affect cell viability.
  • any human and non-human (eukaryotic and prokaryotic) cell types including but not limited to any human organ endothelial cells, epithelial cells, neurons, and/or immune cells, are used in reference to the microfluidic devices and methods described above.
  • the methods described herein are applied to cell patterning in general, using a polymer as a sacrificial barrier for a number of other applications, including 3D printing of tissues, cell co-culture, etc.
  • Patterning for example, is performed by filling microchannels, voids, or other geometric features, using stamping, printing, injection, spraying, or other methods for depositing materials in defined regions or patterns.
  • a reverse thermal gel polymer for controlling cell patterning. At least one microchannel of a cell culture microfluidic device is robustly blocked with an inert, stable, and biocompatible polymer.
  • the methods and devices described herein employ a biocompatible polymer that is modified with cell repulsing factors (which are not limited to semaphorins), cell anti-adhesion or adhesion moieties, growth factors, peptides, or any other molecule or multiple molecules.
  • cell repulsing factors which are not limited to semaphorins
  • cell anti-adhesion or adhesion moieties growth factors, peptides, or any other molecule or multiple molecules.
  • biocompatible polymer gels formed in a cell-unseeded microchannel contain agents and/or molecules, such as drugs, growth factors, and proteins for a controlled release.
  • a polymer-filled microchannel is washed and cellularized.
  • the methods and devices described herein are used for immune cell migration assays through an endothelial monolayer.
  • the endothelial monolayer is a bone marrow on a chip, a blood bone marrow barrier on a chip, or a lymph node on a chip.
  • the methods described herein are automated or performed manually and/or are used with automated or manual OOC devices.
  • a method is directed to visualizing cells at different locations of a cell culture device.
  • a biocompatible polymer gel is used to potentially change a refractive index to more easily visualize different cell layers in bi-, tri-, multi-cell co-culture systems.
  • addition of a polymer gel to a top microchannel of a microfluidic culture allows imaging of a lower microchannel cell layer due to refractive index matching of the polymer and top cell layer.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Sustainable Development (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Clinical Laboratory Science (AREA)
  • Dentistry (AREA)
  • Pulmonology (AREA)
  • Environmental Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physiology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)

Abstract

A device is directed to simulating a function of a tissue, and includes a first structure defining a first chamber, a second structure defining a second chamber, and a porous membrane located at an interface region between the first chamber and the second chamber. The membrane has a first side facing toward the first chamber and a second side facing toward the second chamber, the membrane separating the first chamber from the second chamber. The first side includes a fluid-permeable, stimulus-responsive polymer gel thereon, the second side including at least one layer of cells adhered thereon.

Description

DEVICES, METHODS, AND COMPOSITIONS FOR RESTRICTING CELL
POSITION AND STABILIZING CELLS IN CULTURE SYSTEMS
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority to and benefit of U.S. Provisional Patent Application Serial No. 62/263,383, filed on December 4, 2015, and to U.S. Provisional Patent Application Serial No. 62/333,007, filed on May 6, 2016, each of which is hereby incorporated by reference herein in its entirety.
GOVERNMENT SUPPORT
[0002] The invention was made with Government Support under W91 INF- 12-2-0036 awarded by the Defense Advanced Research Projects Agency of the U.S. Department of Defense. The government has certain rights in the invention.
FIELD OF THE INVENTION
[0003] The present invention relates generally to simulation of a tissue function, and, more particularly, to preventing cell invasion in a microfluidic device.
BACKGROUND OF THE INVENTION
[0004] Human endothelial cells have lengths and widths on the micron scale, e.g., in the 5-25 micron ("μπι") range, when flattened within monolayers in vitro, when lining the vasculature, or within engineered organs-on-chips that mimic in vivo tissue and organ architecture. Additional details in reference to the scale of human endothelial cells are described in "Image Analysis of Endothelial Microstructure and Endothelial Cell Dimensions of Human Arteries - A Preliminary Study," by Bora Garipcan et al., published online on December 10, 2010 (DOI: 10.1002/adem.201080076), which is incorporated herein by reference in its entirety. These cells, similar to many other human cell types, possess great migratory potential that allows them to reconfigure their shape and migrate through small pores (>1 μπι diameter) and to move to adjacent environments. Additional details in reference to cell migration are described in "Endothelial Cell Migration During Angiogenesis," by Laurent Lamalice et al., accepted on January 24, 2007 (DOI: 10.1161/01.RES.0000259593.07661.1e), which is incorporated herein by reference in its entirety. [0005] The cell migration is useful, for example, when simulating angiogenesis or studying immune cell recruitment in vitro. However, this capability can create problems when cells, such as endothelial cells, are cultured on porous membranes within organs-on- chips or other in vitro culture systems. For example, undesired cell migration occurs through the pores and interferes with plating or growth of neighboring tissues, whose presence is required to create critical tissue-tissue interfaces that mimic organ architecture with endothelial cells. This problem can occur when pores are greater than ~1 μιη in diameter. For example, when human umbilical vein endothelial cells ("HUVECs") are seeded in a microfluidic device, cells can escape from a seeded channel to an opposite channel within 1- 3 days of cell seeding. According to this example, the microfluidic device includes two polydimethylsiloxane ("PDMS") top and bottom slabs sandwiching a porous polyethylene terephthalate ("PET") or polycarbonate membrane containing 5 μιη pores to create a top and a bottom channel. This type of cell migration can lead to experimental failures. In other examples, cell escape occurs when using membranes with 3 μιη or 8 μιη pores.
[0006] To prevent cell migration into another channel, smaller pore size of a member has been previously used. However, using pores that are too small to allow cells to pass through also prevents studies where some cell migration is desirable, such as immune cell migration in mature tissue or when cell-cell contacts between the layers is crucial for function (e.g., podocyte-endothelial cell interactions). Accordingly, there is a need for controllable, reversible, and robust blocking of microfluidic channel regions for restricting cell position and/or stabilizing cells in culture systems.
SUMMARY OF THE INVENTION
[0007] According to one embodiment of the present invention, a device includes a first structure defining a first chamber, the first chamber including cells adhered thereon, and the first chamber further including a stimulus-responsive polymer gel on top of the cells.
[0008] According to one aspect of the device described above, the device is a microfluidic device, and the first chamber includes a first microfluidic channel.
[0009] According to another aspect of the device described above, the microfluidic device further includes a second microfluidic channel in fluidic communication with the first microfluidic channel.
[0010] According to yet another aspect of the device described above, the first chamber includes an agent that is blocked from contacting the cells by the gel.
[0011] According to yet another aspect of the device described above, the agent is a drug. [0012] According to yet another aspect of the device described above, the agent is a growth factor.
[0013] According to yet another aspect of the device described above, the gel prevents the cells from differentiating.
[0014] According to yet another aspect of the device described above, the device is housed in a storage container.
[0015] According to yet another aspect of the device described above, the gel is fluid permeable.
[0016] According to yet another aspect of the device described above, the gel is water impermeable.
[0017] According to yet another aspect of the device described above, the device further includes a porous membrane located at an interface region between the first microfluidic channel and the second microfluidic channel, the membrane having a first side and a second side the cells being adhered on the first side.
[0018] According to yet another aspect of the device described above, the stimulus- responsive polymer gel is capable of being dissolved by exposure to an external stimulus.
[0019] According to yet another aspect of the device described above, the external stimulus is selected from a group consisting of temperature, light, pH, a small molecule, an enzyme and a combination of two or more thereof.
[0020] According to yet another aspect of the device described above, the fluid- permeable, stimulus-responsive polymer gel is selected from a group consisting of Pluronic F127, Pluronic F68, poly(N-isopropylacrylamide), alginates, and a combination of two or more thereof.
[0021] According to yet another aspect of the device described above, each of the microfluidic channels is in fluidic communication with ports.
[0022] According to an alternative embodiment of the present invention, a device includes a first structure defining a first chamber, a second structure defining a second chamber; and a porous membrane located at an interface region between the first chamber and the second chamber. The membrane has a first side facing toward the first chamber and a second side facing toward the second chamber, the membrane separating the first chamber from the second chamber. The first side includes cells adhered thereto, the second side including a stimulus-responsive polymer gel thereon.
[0023] According to one aspect of the device described above, the first chamber is in the form of a first microchannel and the second chamber is in the form of a second microchannel. [0024] According to another aspect of the device described above, the first chamber is a top chamber located above the porous membrane and the second chamber is a bottom chamber located below the porous membrane.
[0025] According to yet another aspect of the device described above, the second chamber is filled with the stimulus-responsive polymer gel.
[0026] According to yet another aspect of the device described above, the stimulus- responsive polymer gel is removable in response to an external stimulus.
[0027] According to yet another aspect of the device described above, the gel is fluid permeable.
[0028] According to yet another aspect of the device described above, the gel is water impermeable.
[0029] According to yet another aspect of the device described above, the cells include primary human airway epithelial cells.
[0030] According to yet another aspect of the device described above, the fluid- permeable, stimulus-responsive polymer gel is selected from a group consisting of Pluronic F127, Pluronic F68, poly(N-isopropylacrylamide), alginates, and a combination of two or more thereof.
[0031] According to another alternative embodiment of the present invention, a method is directed to preventing cell differentiation, and includes a) seeding viable cells on to a surface of a device under conditions such that at least a portion adheres thereon. The method also includes b) introducing a stimulus-responsive polymer gel on top of the cells under conditions such that differentiation of the cells is prevented and the cells remain viable.
[0032] According to one aspect of the method described above, the device is a Transwell device.
[0033] According to another aspect of the method described above, the device is a microfluidic device.
[0034] According to yet another aspect of the method described above, the microfluidic device includes a first microfluidic channel in fluidic communication with a second microfluidic channel.
[0035] According to yet another aspect of the method described above, the first microfluidic channel is separated from the second microfluidic channel by a porous membrane, the membrane having a first surface and a second surface.
[0036] According to yet another aspect of the method described above, the cells are adhered to the first surface of the membrane and the gel covers the adhered cells. [0037] According to yet another aspect of the method described above, the method further includes c) feeding the cells with nutrients through the second surface of the membrane while the cells are covered on the first surface by the gel.
[0038] According to yet another aspect of the method described above, the cells are airway epithelial cells and the gel blocks the cells from air exposure, thereby preventing differentiation of the airway epithelial cells.
[0039] According to yet another aspect of the method described above, the method further includes d) removing the gel so that the cells are not prevented from differentiating.
[0040] According to yet another alternative embodiment of the present invention, a method is directed to preserving cells for storage or shipment, and includes a) seeding viable cells on to a surface of a device under conditions such that at least a portion adhere thereon. The method further includes b) introducing a stimulus-responsive polymer gel on top of the cells under conditions such the adhered cells remain viable, thereby preserving the cells.
[0041] According to one aspect of the method described above, the method further includes
c) shipping the cells.
[0042] According to another aspect of the method described above, the method further includes c) storing the cells.
[0043] According to yet another aspect of the method described above, the device is a Transwell device.
[0044] According to yet another aspect of the method described above, the device is a microfluidic device.
[0045] According to yet another aspect of the method described above, the microfluidic device includes a first microfluidic channel in fluidic communication with a second microfluidic channel.
[0046] According to yet another aspect of the method described above, the first microfluidic channel is separated from the second microfluidic channel by a porous membrane, the membrane having a first surface and a second surface.
[0047] According to yet another aspect of the method described above, the cells are adhered to the first surface of the membrane and the gel covers the adhered cells.
[0048] According to yet another aspect of the method described above, the method further includes c) removing the gel so that the cells are not covered by the gel.
[0049] According to yet another aspect of the method described above, the method further includes d) removing the gel so that the cells are not covered by the gel. [0050] According to yet another alternative embodiment of the present invention, a method is directed to restricting the position of cells in a microfluidic device, the device including a first region and a second region. The method includes polymerizing a biopolymer material in the first region, seeding cells such that they attach to the second region but are prevented from attaching to the first region by the polymerized material, and after the seeding, depolymerizing and removing the biopolymer material from the first region.
[0051] According to one aspect of the method described above, the first region and second region are separated by a porous membrane, the porous membrane having top and bottom surfaces.
[0052] According to another aspect of the method described above, the method further includes imaging cell migration across the porous membrane.
[0053] According to yet another aspect of the method described above, the depolymerizing is in response to applying an external stimulus.
[0054] According to yet another aspect of the method described above, the external stimulus is one or more of a temperature application, a light application, a pH application, an enzyme application and a small molecule application.
[0055] According to yet another aspect of the method described above, the polymerizing of the biopolymer material includes incubation at a temperature of approximately 37 °Celsius for approximately 30 minutes, the biopolymer material being a Pluronic F127 biopolymer.
[0056] According to yet another aspect of the method described above, the incubation results in a solidified material that blocks cell contact with the first region.
[0057] According to yet another aspect of the method described above, the first region includes a top microfluidic compartment selected from the group consisting of a microfluidic chamber or microfluidic channel.
[0058] According to yet another aspect of the method described above, the second region includes a bottom microfluidic compartment selected from the group consisting of a microfluidic chamber or microfluidic channel.
[0059] According to yet another aspect of the method described above, the first region includes a top surface of a membrane, or portion thereof.
[0060] According to yet another aspect of the method described above, the first region includes a bottom surface of a membrane, or portion thereof.
[0061] According to yet another aspect of the method described above, the microfluidic device is an organ-on-chip device. [0062] According to yet another aspect of the method described above, the method further including seeding cells in the first region.
[0063] According to yet another aspect of the method described above, the cells in the first region are different from the cells in the second region.
[0064] According to yet another alternative embodiment of the present invention, a method is directed to restricting the position of cells in a microfluidic device, the device including a top compartment and a bottom compartment separated by a porous membrane. The method includes a) forming a gel in the top or bottom compartment or membrane, or portion thereof, and b) seeding cells on a region of the top or bottom compartments or membrane that is not blocked by the gel, thereby restricting the position of the cells in the microfluidic device.
[0065] According to one aspect of the method described above, the method further includes c) removing the gel from the microfluidic device.
[0066] According to another aspect of the method described above, the gel is removed by a method comprising depolymerizing the gel in response to applying an external stimulus.
[0067] According to yet another aspect of the method described above, the external stimulus is one or more of a temperature application, a light application, a pH application, an enzyme application and a small molecule application.
[0068] According to yet another aspect of the method described above, the forming of the gel in step a) includes polymerizing a biopolymer material.
[0069] According to yet another aspect of the method described above, the polymerizing of the biopolymer material includes incubation at a temperature of approximately 37 °Celsius for approximately 30 minutes, the biopolymer material being a Pluronic F127 biopolymer.
[0070] According to yet another aspect of the method described above, the incubation results in a solidified material that blocks contact with the cells in a region of the microfluidic device.
[0071] According to yet another aspect of the method described above, the top microfluidic compartment is selected from the group consisting of a microfluidic chamber or microfluidic channel.
[0072] According to yet another aspect of the method described above, the bottom microfluidic compartment is selected from the group consisting of a microfluidic chamber or microfluidic channel.
[0073] According to yet another aspect of the method described above, the microfluidic device is an organ-on-chip device or a Transwell device. [0074] According to yet another aspect of the method described above, the microfluidic device further includes ports in fluid communication with the top and bottom compartments and the seeding comprises introducing cells into the ports in a flow of culture media.
[0075] According to yet another alternative embodiment of the present invention, a method is directed to restricting the position of cells in a microfluidic device, the device including a porous membrane, the porous membrane including i) pores and ii) first and second sides. The method includes a) forming a gel in the first or second side of the membrane, or portion thereof, and b) seeding cells on a region of the membrane on the side opposite to the side including the gel under conditions such that the cells are prevented by the gel from moving through the pores, thereby restricting the position of the cells in the microfluidic device.
[0076] According to one aspect of the method described above, the method further includes c) removing the gel from the microfluidic device.
[0077] According to another aspect of the method described above, the gel is a water impermeable gel.
[0078] According to yet another aspect of the method described above, the gel is a calcium alginate gel and the gel is removed by washing out or chelating the calcium in the calcium alginate gel.
[0079] According to yet another aspect of the method described above, the microfluidic device is an organ-on-chip device or a Transwell device.
[0080] According to yet another aspect of the method described above, the gel is a collagen gel and the collagen gel is removed with an enzyme.
[0081] Additional aspects of the invention will be apparent to those of ordinary skill in the art in view of the detailed description of various embodiments, which is made with reference to the drawings, a brief description of which is provided below.
BRIEF DESCRIPTION OF THE DRAWINGS
[0082] FIG. 1A is an exploded perspective view illustrating a device for simulating a function of a tissue, in accordance with one embodiment.
[0083] FIG. IB is an assembled perspective view of the device shown in FIG. 1 A.
[0084] FIG. 2A is a perspective view illustrating a device for simulating a function of a tissue, in accordance with another embodiment.
[0085] FIG. 2B shows the device of FIG. 2A with a biopolymer-filled bottom microchannel. [0086] FIG. 2C shows the device of FIG. 2B with a cell-seeded top microchannel.
[0087] FIG. 2D shows the device of FIG. 2C with the biopolymer removed from the bottom microchannel.
[0088] FIG. 2E shows the device of FIG. 2D with a cell layer seeded in the bottom microchannel.
[0089] FIG. 3A shows a perspective view of an organ-on-chip (OOC) device, in accordance with yet another embodiment.
[0090] FIG. 3B shows an exploded perspective view of the OOC device of FIG. 3 A.
[0091] FIG. 3C shows a cutaway perspective view with enlarged features of the OOC device of FIG. 3B.
[0092] FIG. 3D shows a cutaway side view with enlarged features of the OOC device of FIG. 3C.
[0093] FIG. 4 illustrates a system, in accordance with yet another embodiment, in which cells are seeded on top of a porous membrane.
[0094] FIG. 5 illustrates a system, in accordance with yet another embodiment, in which cells are submerged underneath a biopolymer.
[0095] FIG. 6A illustrates a TRANSWELL® insert system, in accordance with yet another embodiment.
[0096] FIG. 6B illustrates a biopolymer inserted in a bottom compartment of the system of FIG. 6 A.
[0097] FIG. 6C illustrates cells seeded in a top compartment of the system of FIG. 6A.
[0098] FIG. 7A illustrates a TRANSWELL® insert system, in accordance with yet another embodiment.
[0099] FIG. 7B illustrates a biopolymer inserted in a top compartment of the system of FIG. 7A.
[00100] FIG. 7C illustrates cells seeded in a bottom compartment of the system of FIG. 7A.
[00101] FIG. 7D illustrates the biopolymer removed from the top compartment of the system of FIG. 7A.
[00102] FIG. 7E illustrates another cell type added to the top compartment of the system of FIG. 7 A.
[00103] FIG. 7F illustrates a migration assay in the system of FIG. 7A.
[00104] FIG. 8 shows a timeline illustrating effects of delaying differentiation of cells. [00105] FIG. 9A shows a microscopic image of epithelial morphology in a sample without polymer exposure.
[00106] FIG. 9B shows a microscopic image of epithelial morphology in a sample with polymer exposure.
[00107] While the invention is susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and will be described in detail herein. It should be understood, however, that the invention is not intended to be limited to the particular forms disclosed. Rather, the invention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims.
DETAILED DESCRIPTION
[00108] While this invention is susceptible of embodiment in many different forms, there is shown in the drawings and will herein be described in detail preferred embodiments of the invention with the understanding that the present disclosure is to be considered as an exemplification of the principles of the invention and is not intended to limit the broad aspect of the invention to the embodiments illustrated. For purposes of the present detailed description, the singular includes the plural and vice versa (unless specifically disclaimed); the words "and" and "or" shall be both conjunctive and disjunctive; the word "all" means "any and all"; the word "any" means "any and all"; and the word "including" means "including without limitation."
Definitions
[00109] The term "microfluidic" as used herein relates to components where moving fluid is constrained in or directed through one or more chambers or channels wherein one or more dimensions are 1 millimeter ("mm") or smaller (microscale). Microfluidic channels may be larger than microscale in one or more directions, though the channel(s) will be on the microscale in at least one direction. In some instances, the geometry of a microfluidic channel may be configured to control the fluid flow rate through the channel (e.g. increase channel height to reduce shear). Microfluidic channels can be formed of various geometries to facilitate a wide range of flow rates through the channels. Microfluidic devices include (but are not limited to) organ-on-chip devices and Transwell devices.
[00110] "Channels" are pathways (whether straight, curved, single, multiple, in a network, etc.) through a medium (e.g., silicon) that allow for movement of liquids and gasses. Channels, thus, can connect other components, i.e., keep components "in communication" and more particularly, "in fluidic communication," and still more particularly, "in liquid communication." Such components include, but are not limited to, liquid-intake ports and gas vents. Microchannels are channels with dimensions less than 1 mm and greater than 1 micron.
[00111] As used herein, the phrases "connected to," "coupled to," "in contact with" and "in communication with" refer to any form of interaction between two or more entities, including mechanical, electrical, magnetic, electromagnetic, fluidic, and thermal interaction. For example, in one embodiment, channels in a microfluidic device are in fluidic communication with cells and (optionally) a fluid source such as a fluid reservoir. Two components may be coupled to each other even though they are not in direct contact with each other. For example, two components may be coupled to each other through an intermediate component (e.g., tubing or other conduit).
[00112] Generally, according to one feature described below, undesirable cell migration is prevented when the migration occurs through a membrane with a pore size greater than 1 μιη in diameter and when cells (such as endothelial cells) are cultured thereon in a microfluidic device, such as an organ-on-chip ("OOC") device. To prevent cells from a first microchannel invading a second opposite microchannel, and, thus, interfering with plating or growth of tissue-specific cells in the second opposite microchannel, an approach includes seeding cells in the first microchannel of a microfluidic cell culture device (e.g., the OOC device) while the second opposite microchannel has a stimulus-responsive biocompatible polymer. Upon exposure to a first stimulus, the biocompatible polymer forms a gel to prevent cell invasion. The gel is readily dissolved or removed upon exposure to a second stimulus, when it is desired to plate another cell type in the second opposite microchannel. According to some examples, the gel includes a collagen type of gel, a water impermeable type of gel, and/or other types of gels.
[00113] Referring to FIGs. 1A and IB, an exemplary of a microfluidic device 100 is in the form of an OOC device that includes a top slab 102 separated from a bottom slab 104 by a porous membrane 106. The top slab 102 defines a first chamber 108 (which is illustrated in the form of a top microchannel), and the second slab 104 defines a second chamber 110 (which is illustrated in the form of a bottom microchannel). The porous membrane 106 is located at an interface region between the first chamber 108 and the second chamber 110, separating the two chambers 108, 110, and has a first side 112 facing toward the first chamber 108 and a second side 114 facing toward the second chamber 110. A first fluid inlet 116 is provided for fluid flow into the top microchannel 108, and a second fluid inlet 118 is provided for fluid flow into the bottom microchannel 110.
[00114] Referring generally to FIGs. 2A-2E, the culturing and prevention of undesirable cell migration is achieved, for example, in micro-, meso-, and/or macro-fluidic settings. Initially, in reference to FIG. 2A, the microfluidic device 100 is provided with the top and bottom microchannels 108, 110 empty (e.g., lacking any fluids, cultured cells, or gels). Then, in reference to FIG. 2B, the bottom microchannel 110 is temporally or temporarily filled with a biocompatible polymer gel 120 to prevent cell invasion. Referring to FIG. 2C, the top microchannel 108 is seeded with one or more cell layers 122. Referring to FIG. 2D, the polymer gel 120 is removed from the bottom microchannel 110. According to one example, the polymer gel 120 is removed with enzymes. The removal of the polymer gel 120 typically occurs when a user desires to plant another cell type in the bottom microchannel 110. Then, referring to FIG. 2E, the bottom microchannel 110 is seeded with one or more cell layers 124 (e.g., a blood-brain barrier or epithelial-endothelial co-culture systems).
[00115] Referring generally to FIGs. 3A-3D, another exemplary embodiment is directed to an OOC device 200 that includes a body 201 with an upper body segment 202 and a lower body segment 204. The upper body segment 202 and the lower body segment 204 are preferably made of a polymeric material, such as PDMS, PMMA, polycarbonate, COP/CoC, polyurethane, or SBS/SEBS.
[00116] Referring specifically to FIGs. 3B and 3C, the OOC device 200 includes a porous membrane 206 that is located at an interface region between the upper body segment 202 and the lower body segment 204, separating a top microchannel 208 from a bottom microchannel 210. The membrane 206 has a first side 212 facing toward the top microchannel 208 and a second side 214 facing toward the bottom microchannel 210. A first fluid inlet 216 is provided for fluid flow into the top microchannel 208, and a second fluid inlet 218 is provided for fluid flow into the bottom microchannel 210.
[00117] Referring specifically to FIG. 3B, a first fluid outlet 217 is provided for fluid flow exiting the top microchannel 208, and a second fluid outlet 219 is provided for fluid flow exiting the bottom microchannel 210. Optionally, the OOC device 200 includes one or more additional top and bottom microchannels, such as cross-flow microchannels 221, 222, with respective third fluid inlet and outlet 223, 224.
[00118] Referring specifically to FIG. 3C, the membrane 206 includes a plurality of pores 226 through which cells are able to migrate between the top microchannel 208 and the bottom microchannel 210. The size of the pores 226 is selected in accordance with achieving a desired migration, simulating a specific function in vitro.
[00119] Referring specifically to FIG. 3D, the top microchannel 208 is filled at least in part with a biocompatible polymer gel 220, which is attached to the top surface 212 of the membrane 206. The bottom microchannel 210 includes a cell layer 222, which is seeded onto the bottom surface 214 of the membrane 206. While the polymer gel 220 is in place on the top surface 221 of the membrane 206, the polymer gel 220 prevents undesired or inadvertent migration of cells 222 from the bottom microchannel 210 into the top microchannel 208. When migration of cells 222 is desired, the polymer gel 220 is removed at least in part from the top microchannel 208.
[00120] Referring generally to FIGs. 4 and 5, cells seeded on top of a porous membrane are submerged underneath a polymer gel (i.e., in the same microchannel as the cultured cells), according to an alternative embodiment. In specific reference to FIG. 4, a microfluidic device 300 includes a top microchannel 308, a porous membrane 306, and a bottom microchannel 310. Optionally, the microfluidic device 300, including one or more of its features, is similar to or identical to the microfluidic device 100 illustrated in FIGs. 1A and IB. According to another optional embodiment, the microfluidic device 300 includes one or more features of a TRANSWELL® insert system 309, for a static cell culture.
[00121] The microfluidic device 300 includes primary human airway epithelial cells 322 that are seeded on top of the porous membrane 306, within the top microchannel 308. Additionally, the microfluidic device 300 includes a cell culture medium 323 in the bottom microchannel 310. Referring specifically to FIG. 5, the cells 322 are submerged underneath underneath a biopolymer gel 320. The cells 322 are kept submerged under the polymer without disrupting cell monolayer quality and the cell ability to differentiate in vitro. This aspect is helpful in serving at least two purposes: (1) to delay differentiation of desired cell type, and (2) to preserve and stabilize live cell layers 322 submerged under biopolymer gel 320 for shipment of OOC devices or for reducing the total amount of medium required. Thus, the microfluidic device 300 is beneficial in stabilizing cell cultures or replacing cell culture medium in cell-containing platforms for maintenance or shipment from one location to another. For example, by filling a microchannel with a biopolymer gel 320, the total amount of cell culture medium required is reduced.
[00122] Referring generally to FIGs. 6A-6C, an exemplary method is illustrated in which cells are seed in a top compartment and a biopolymer gel is polymerized in a bottom compartment. Referring specifically to FIG. 6A, a microfluidic device 400 includes similar or identical features to the TRANSWELL® insert system 309 illustrated in FIGs. 4 and 5. By way of example, the microfluidic device 400 includes a top compartment 408 (e.g., an insert), a porous membrane 406, and a bottom compartment 410 (e.g., a well). Referring specifically to FIG. 6B, a biopolymer gel 420 is polymerized in the bottom compartment 410. Referring specifically to FIG. 6C, cells 422 are seeded on top of the membrane 406, in the top compartment 408. This approach is useful, for example, for assays such as immune cell chemotaxis assays in which a single endothelial layer is required on large-pore (e.g. 3-8 μπι) membrane.
[00123] According to one feature, the microfluidic device 400 and the biopolymer gel 420 (e.g., filter-sterilized biocompatible polymer) are incubated under a condition that maintains the biopolymer gel 420 in a liquid form. For example, the microfluidic device and a biocompatible polymer Pluronic F127 are incubated at about 4° C for about 30 minutes. The procedure is performed while the top compartment 408 (reserved for cell seeding) is clamped or blocked on both ends to prevent polymer leak. This step is carried out quickly, and, then, the polymer-filled microdevice is placed at a temperature selected for allowing the polymer to gel. For example, assuming that Pluronic F127 is the selected biocompatible polymer, the polymer-filled microdevice is placed in a 37° C incubator for about 15 min to allow the biopolymer gel 420 to transition from liquid form to gel form. Meanwhile, a suspension of cells 422, e.g., endothelial cells such as human umbilical vein endothelial cells ("HUVECs"), is prepared at a desired concentration, with the cells 422 being added quickly to the top compartment 408 and allowed to adhere overnight. A culture medium of the cell-seeded compartment 408 is replaced with a fresh medium, e.g., by connecting the microfluidic device 400 to microfluidic flow. The microfluidic device 400 is continuously monitored for any sign of cell escape into the polymer-filled compartment 410.
[00124] Referring generally to FIGs. 7A-7F, another exemplary method is illustrated in which a first type of cells migrates between compartments of a microfluidic device towards a second type of cells. Referring specifically to FIG. 7A, a microfluidic device 500 includes similar or identical features to the TRANSWELL® insert system 309 illustrated in FIGs. 4 and 5. By way of example, the microfluidic device 500 includes a top compartment 508, a porous membrane 506, and a bottom compartment 510. Referring specifically to FIG. 7B, a biopolymer gel 520 is polymerized in the top compartment 508. Referring specifically to FIG. 7C, a first type of cells 522 is seeded on the undersurface of the membrane 506, in the bottom compartment 510. Referring specifically to FIG. 7D, the biopolymer gel 520 is depolymerized and removed from the top compartment 508. Referring specifically to FIG. 7E, a second type of cells 525 is added to the top compartment 508. Referring specifically to FIG. 7F, a migration assay is performed to analyze (e.g., image) migration of one or more cells 523 of the first type of cells 522 that migrate through the membrane 506, from the bottom compartment 510 to the top compartment 508.
[00125] Referring to FIG. 8, a timeline illustrates delaying differentiation of cells in vitro without causing adverse effects on cell behavior and/or quality. The delaying of the cellular differentiation is for a desired period of time, e.g., for a number of days or a number of hours. To hold back the differentiation process, for example, cells are fed with nutrients and kept alive through one side (e.g., basal side) while the other side of the cells (e.g., apical side) is exposed to the biopolymer gel. By way of example, air exposure is a known inducer of cellular differentiation for cells like airway epithelial cells. Additionally, submerging the cells apically with polymer delays differentiation as long as a user intends.
[00126] By way of example, a first set of epithelial cells (Set 1) serves as a control group of samples (e.g., confluent epithelial monolayers) that are not exposed to a biopolymer gel. The first set of epithelial cells are directly taken to an air-liquid interface ("ALI") 24 days prior to the microscopic observation of cell monolayer and cilia beating. ALI is a key driver of airway epithelial cell differentiation into ciliated cells.
[00127] In a second set of epithelial cells (Set 2), which is exposed to a biopolymer gel, a replacement of an apical medium with the biopolymer gel is also performed 24 days prior to the microscopic observation. Confluent human airway epithelial cells are submerged under the biopolymer gel for 7 days within a microfluidic device (e.g., an OOC device as described above). After the replacement of the apical medium with the biopolymer gel, the ALI induction is performed, later, only 17 days prior to the microscopic observation. Thus, differentiation is achieved by removing the biopolymer gel and introducing air into the microchannel to form the ALI. As discussed below, no adverse effects re observed in cell behavior and/or quality between the first set of epithelial cells and the second set of epithelial cells.
[00128] Referring generally to FIGs. 9A and 9B, sample microscopic images illustrate similar results in both sets of epithelial cells discussed above in reference to FIG. 8. Referring specifically to FIG. 9A, a phase-contrast microscopic image shows the first set of cells, which has not been exposed to the biopolymer gel, on day 24 (post-ALI) with a nice cobblestone packed epithelial morphology. Referring specifically to FIG. 9B, a phase- contrast microscopic images shows the second set of cells, which has been exposed to the biopolymer gel, on day 17 (post-ALI) with a similar nice cobblestone packed epithelial morphology. Cilia beating (10X slowed down) was measured for both sets of cells, with good and comparable measures in both sets of cells.
[00129] Thus, the cells that are overlaid with the biopolymer gel not only have a normal cobblestone packed epithelial monolayer (by benchmarking against and similar to polymer- untreated cells), but also exhibit an ability to differentiate into ciliated epithelium. However, the cell differentiation is delayed compared to the control cultures by approximately the number of days that the cells are kept covered with the polymer and held in a "suspended state." This indicates that the cells are stabilized biologically by the biopolymer gel described herein to avoid unwanted differentiation, or potentially de-differentiation, during transport or long-term tissue maintenance. In addition, the extremely high viscosity of the gelled polymer prevents shear-induced damage to the tissue during transport and handling. This aspect is beneficial at least for shipping organs, tissues, or cells in a microfluidic device when they can be cultured in a suspended state. Upon receipt of the microfluidic device, the user removes the polymer, adds medium (or air), and reboots the differentiation process necessary to complete a desired study.
[00130] Exemplary biocompatible polymer gels for use in reference to any of the gels discussed above, include, but are not limited to the following:
- Pluronic F127 (e.g., -25% w/v) and/or Pluronic F68, which both
exhibit a reverse thermal gelling behavior, which gels at high temperatures (e.g., ~ 20° C) and melts at low temperatures (e.g., 4°
C);
- Poly(N-isopropylacrylamide) ("PNIPAAm") polymer, which is
modified to gel at about 37° C and to contract at a higher or lower temperature to facilitate gel removal; and
Alginates, which gels in the presence of calcium but dissolves when calcium chelators are added.
[00131] Pluronic F127 prevents endothelial cell escape and invasion into a second microchannel of an organ chip in an in vitro assay. Pluronic F127 is a triblock co-polymer that exhibits a reverse thermal gelling behavior in which, unlike most gels (e.g., agarose, gelatin, etc.), it solidifies at high temperatures (e.g., >20° C) and melts at low temperatures (e.g., ~ 4° C). This behavior is applicable in many biomedical applications, such as areas of tissue engineering, drug delivery, and controlled compound release into tissue. Additional details regarding Pluronic F127 are described in "Applications of Thermo-Reversible Pluronic F-127 Gels in Pharmaceutical Formulations," by J. J. Escobar-Chavez et al., published November 27, 2006 (J. Pharm. Pharmaceut. Sci. 9 (3):339-358), which is incorporated herein by reference in its entirety. Pluronic F127 is also useful in other areas, such as 3D printing.
[00132] Pluronic F68 a similar behavior to Pluronic F127. Additional details regarding Pluronic F68 are described in "Rheological Properties of Thermo-Responsive Microemulsion-based Gels Formed by Pluronic F68," by Zhao et al. (J. Chem. Pharm. Res., 2014, 6(7): 2067-2072), which is incorporated herein by reference in its entirety. Other polymers include any other polymer or materials with the ability to polymerize and depolymerize in a range of about 0-37° C. Such polymers or materials do not interfere with cell adhesion, growth, or differentiation (depending on the tested cell). Alternatively, the biocompatible polymer, according to some examples, is Pluronic F127 having 1-50% weight/volume ("w/v"), 15-30% w/v, or 25% w/v.
[00133] The PNIPAAm polymer provides the ability to be washed out of a microchannel of a microfluidic cell culture device (e.g., an organ chip) when cells (e.g., a different types of cells) are desired to be seeded in the microchannel. Alginates can also be used which can be gelled with calcium and dissolved with calcium chelators. Optionally, a low viscosity of the biocompatible polymer is at about 4° C allows filling or emptying of very small microchannels and other features without affecting cells or devices due to pressure and shear. Optionally, yet, biocompatible polymers described herein are optically transparent and non- fluorescent in typical imaging wavelengths, unlike some other thermally-responsive gels (e.g. PNIPAAm).
[00134] According to one aspect, the stimulus responsive biocompatible polymer gels (which are not limited to thermally-responsive biocompatible polymer gels) are optionally or alternatively overlaid on top of a cultured cell monolayer. This approach, for example, delays initiation of a certain cell process (such as cell differentiation) until the organ chip is ready to use, and/or to protect submerged live cell layers from shear-induced damage during transport and handling.
[00135] By way of example, the biocompatible polymer gel is optionally selected from polymers that offer one or more of the following characteristics: (1) biocompatibility such that the biocompatible polymer gel does not interfere with culture, growth, and potentially differentiation of seeded cells; (2) the polymer gel does not readily leak into or block a cell- containing microchannel; and (3) the first microchannel is polymerized and de-polymerized using one or more stimuli that have minimal or no cytotoxicity or significant biological effects. For example, in reference to minimal biological effects, a change in temperature at an approximate range of 4° - 37° C is typically well-tolerated by many cells, but a large change in pH can have detrimental impact on the cells and cause cytotoxicity or cellular stress.
[00136] According to yet another aspect, the biocompatible polymer gel is nonbiodegradable. For example, the biocompatible polymer gel does not include any extracellular matrix proteins that degrade by cells or that affect cell growth and/or functions.
[00137] According to yet another aspect, based on the polymer gel being of non-rigid form, a device is used for mechanical actuation or stimulation of the tissue without affecting the blocking polymer gel. Optionally, cell-compatible reversal and polymer removal processes avoid harsh chemical, ultraviolet ("UV"), and/or thermal treatments. The methods described herein are simple, fast, and sterile process-compatible methods. Optionally, yet, in addition to or instead of restricting cell position for a desirable period of time, biocompatible polymers can also be utilized to stabilize cell cultures in culture devices. For example, biocompatible polymers protect cells against movement-induced fluid shear forces and/or minimize the total amount of medium requirements. The protection and/or minimization features are beneficial for shipping or storage of tissues, organs, or cells in a microfluidic cell culture device (e.g., an organ chip) in a way that optimizes the respective structure and function.
[00138] According to yet another aspect, the biocompatible polymer transitions between liquid and gel states at about 25° C for 25% w/v solutions. This biocompatible polymer enables removal at a cell-compatible temperature, such as 4° C. The biocompatible polymer is also optically clear and is non-autofluorescent, allowing the biocompatible polymer to be used without interfering with imaging applications. The biocompatible polymer does not prevent or negatively influence cell attachment and growth in a culture. For example, a monolayer becomes evident on day two of post seeding in a gel -free microchannel. The cell layer morphology is comparable to the morphology in chips that are seeded without polymer in the opposite microchannel. Importantly, no cell escape occurs to the unseeded microchannel.
[00139] In alternative embodiments, the biocompatible polymer undergoes polymerization-de-polymerization via a method other than one having a temperature change, as long as the method does not affect cell viability. Optionally or alternatively, any human and non-human (eukaryotic and prokaryotic) cell types, including but not limited to any human organ endothelial cells, epithelial cells, neurons, and/or immune cells, are used in reference to the microfluidic devices and methods described above.
[00140] In yet other alternative embodiments, the methods described herein are applied to cell patterning in general, using a polymer as a sacrificial barrier for a number of other applications, including 3D printing of tissues, cell co-culture, etc. Patterning, for example, is performed by filling microchannels, voids, or other geometric features, using stamping, printing, injection, spraying, or other methods for depositing materials in defined regions or patterns. In some applications, a reverse thermal gel polymer for controlling cell patterning. At least one microchannel of a cell culture microfluidic device is robustly blocked with an inert, stable, and biocompatible polymer.
[00141] In yet other alternative embodiments, the methods and devices described herein employ a biocompatible polymer that is modified with cell repulsing factors (which are not limited to semaphorins), cell anti-adhesion or adhesion moieties, growth factors, peptides, or any other molecule or multiple molecules. Optionally or alternatively, biocompatible polymer gels formed in a cell-unseeded microchannel contain agents and/or molecules, such as drugs, growth factors, and proteins for a controlled release. In further optional or alternative embodiments, a polymer-filled microchannel is washed and cellularized.
[00142] In yet other alternative embodiments, the methods and devices described herein are used for immune cell migration assays through an endothelial monolayer. For example, the endothelial monolayer is a bone marrow on a chip, a blood bone marrow barrier on a chip, or a lymph node on a chip. Optionally or alternatively, the methods described herein are automated or performed manually and/or are used with automated or manual OOC devices.
[00143] In yet other applications, a method is directed to visualizing cells at different locations of a cell culture device. For example, a biocompatible polymer gel is used to potentially change a refractive index to more easily visualize different cell layers in bi-, tri-, multi-cell co-culture systems. In another example, addition of a polymer gel to a top microchannel of a microfluidic culture allows imaging of a lower microchannel cell layer due to refractive index matching of the polymer and top cell layer.
[00144] Each of these embodiments and obvious variations thereof is contemplated as falling within the spirit and scope of the claimed invention, which is set forth in the following claims. Moreover, the present concepts expressly include any and all combinations and subcombinations of the preceding elements and aspects.

Claims

CLAIMS What is claimed is:
1. A device comprising a first structure defining a first chamber, the first chamber including cells adhered thereon, the first chamber further including a stimulus-responsive polymer gel on top of the cells.
2. The device of claim 1, wherein the device is a microfiuidic device, the first chamber including a first microfiuidic channel.
3. The device of claim 2, wherein the microfiuidic device further includes a second microfiuidic channel in fluidic communication with the first microfiuidic channel.
4. The device of claim 1, wherein the first chamber includes an agent that is blocked from contacting the cells by the gel.
5. The device of claim 4, wherein the agent is a drug.
6. The device of claim 4, wherein the agent is a growth factor.
7. The device of claim 1, wherein the gel prevents the cells from differentiating.
8. The device of claim 1, wherein the device is housed in a storage container.
9. The device of claim 1, wherein the gel is fluid permeable.
10. The device of claim 1, wherein the gel is water impermeable.
11. The device of claim 3, further comprising a porous membrane located at an interface region between the first microfiuidic channel and the second microfiuidic channel, the membrane having a first side and a second side the cells being adhered on the first side.
12. The device of claim 1, wherein the stimulus-responsive polymer gel is capable of being dissolved by exposure to an external stimulus.
13. The device of claim 12, wherein the external stimulus is selected from a group consisting of temperature, light, pH, a small molecule, an enzyme and a combination of two or more thereof.
14. The device of claim 9, wherein the fluid-permeable, stimulus-responsive polymer gel is selected from a group consisting of Pluronic F127, Pluronic F68, poly(N- isopropylacrylamide), alginates, and a combination of two or more thereof.
15. The device of claim 1, wherein each of the microfluidic channels is in fluidic communication with ports.
16. A device comprising:
a first structure defining a first chamber;
a second structure defining a second chamber; and
a porous membrane located at an interface region between the first chamber and the second chamber, the membrane having a first side facing toward the first chamber and a second side facing toward the second chamber, the membrane separating the first chamber from the second chamber, the first side including cells adhered thereto, the second side including a stimulus-responsive polymer gel thereon.
17. The device of claim 16, wherein the first chamber is in the form of a first microchannel and the second chamber is in the form of a second microchannel.
18. The device of claim 16, wherein the first chamber is a top chamber located above the porous membrane and the second chamber is a bottom chamber located below the porous membrane.
19. The device of claim 16, wherein the second chamber is filled with the stimulus- responsive polymer gel.
20. The device of claim 7, wherein the stimulus-responsive polymer gel is removable in response to an external stimulus.
21. The device of claim 16, wherein the gel is fluid permeable.
22. The device of claim 16, wherein the gel is water impermeable.
23. The device of claim 16, wherein the cells include primary human airway epithelial cells.
24. The device of claim 21, wherein the fluid-permeable, stimulus-responsive polymer gel is selected from a group consisting of Pluronic F127, Pluronic F68, poly(N- isopropylacrylamide), alginates, and a combination of two or more thereof.
25. A method of preventing cell differentiation, comprising:
a) seeding viable cells on to a surface of a device under conditions such that at least a portion adheres thereon; and
b) introducing a stimulus-responsive polymer gel on top of the cells under conditions such that differentiation of the cells is prevented and the cells remain viable.
26. The method of claim 25, wherein the device is a Transwell device.
27. The method of claim 25, wherein the device is a microfluidic device.
28. The method of claim 27, wherein the microfluidic device includes a first microfluidic channel in fluidic communication with a second microfluidic channel.
29. The method of claim 28, wherein the first microfluidic channel is separated from the second microfluidic channel by a porous membrane, the membrane having a first surface and a second surface.
30. The method of claim 29, wherein the cells are adhered to the first surface of the membrane and the gel covers the adhered cells.
31. The method of claim 30, further comprising c) feeding the cells with nutrients through the second surface of the membrane while the cells are covered on the first surface by the gel.
32. The method of claim 25, wherein the cells are airway epithelial cells and the gel blocks the cells from air exposure, thereby preventing differentiation of the airway epithelial cells.
33. The method of claim 31, further comprising d) removing the gel so that the cells are not prevented from differentiating.
34. A method of preserving cells for storage or shipment, comprising:
a) seeding viable cells on to a surface of a device under conditions such that at least a portion adhere thereon; and
b) introducing a stimulus-responsive polymer gel on top of the cells under conditions such the adhered cells remain viable, thereby preserving the cells.
35. The method of claim 34, further comprising c) shipping the cells.
36. The method of claim 34, further comprising c) storing the cells.
37. The method of claim 34, wherein the device is a Transwell device.
38. The method of claim 34, wherein the device is a microfluidic device.
39. The method of claim 38, wherein the microfluidic device includes a first microfluidic channel in fluidic communication with a second microfluidic channel.
40. The method of claim 39, wherein the first microfluidic channel is separated from the second microfluidic channel by a porous membrane, the membrane having a first surface and a second surface.
41. The method of claim 40, wherein the cells are adhered to the first surface of the membrane and the gel covers the adhered cells.
42. The method of claim 34, further comprising c) removing the gel so that the cells are not covered by the gel.
43. The method of claims 35 or 36, further comprising d) removing the gel so that the cells are not covered by the gel.
44. A method for restricting the position of cells in a microfluidic device, the device including a first region and a second region, the method comprising:
polymerizing a biopolymer material in the first region;
seeding cells such that they attach to the second region but are prevented from attaching to the first region by the polymerized material; and
after the seeding, depolymerizing and removing the biopolymer material from the first region.
45. The method of claim 44, wherein the first region and second region are separated by a porous membrane, the porous membrane having top and bottom surfaces.
46. The method of claim 45, further comprising imaging cell migration across the porous membrane.
47. The method of claim 44, wherein the depolymerizing is in response to applying an external stimulus.
48. The method of claim 47, wherein the external stimulus is one or more of a temperature application, a light application, a pH application, an enzyme application and a small molecule application.
49. The method of claim 48, wherein the polymerizing of the biopolymer material includes incubation at a temperature of approximately 37 °Celsius for approximately 30 minutes, the biopolymer material being a Pluronic F127 biopolymer.
50. The method of claim 49, wherein the incubation results in a solidified material that blocks cell contact with the first region.
51. The method of claim 44, wherein the first region includes a top microfluidic compartment selected from the group consisting of a microfluidic chamber or microfluidic channel.
52. The method of claim 51, wherein the second region includes a bottom microfluidic compartment selected from the group consisting of a microfluidic chamber or microfluidic channel.
53. The method of claim 44, wherein the first region includes a top surface of a membrane, or portion thereof.
54. The method of claim 44, wherein the first region includes a bottom surface of a membrane, or portion thereof.
55. The method of claim 44, wherein the microfluidic device is an organ-on-chip device.
56. The method of claim 45, further comprising seeding cells in the first region.
57. The method of claim 56, wherein the cells in the first region are different from the cells in the second region.
58. A method for restricting the position of cells in a microfluidic device, the device including a top compartment and a bottom compartment separated by a porous membrane, the method comprising:
a) forming a gel in the top or bottom compartment or membrane, or portion thereof; and
b) seeding cells on a region of the top or bottom compartments or membrane that is not blocked by the gel, thereby restricting the position of the cells in the microfluidic device.
59. The method of claim 58, further comprising c) removing the gel from the microfluidic device.
60. The method of claim 59, wherein the gel is removed by a method comprising depolymerizing the gel in response to applying an external stimulus.
61. The method of claim 60, wherein the external stimulus is one or more of a temperature application, a light application, a pH application, an enzyme application and a small molecule application.
62. The method of claim 58, wherein the forming of the gel in step a) includes polymerizing a biopolymer material.
63. The method of claim 62, wherein the polymerizing of the biopolymer material includes incubation at a temperature of approximately 37 °Celsius for approximately 30 minutes, the biopolymer material being a Pluronic F127 biopolymer.
64. The method of claim 63, wherein the incubation results in a solidified material that blocks contact with the cells in a region of the microfluidic device.
65. The method of claim 58, wherein the top microfluidic compartment is selected from the group consisting of a microfluidic chamber or microfluidic channel.
66. The method of claim 58, wherein the bottom microfluidic compartment is selected from the group consisting of a microfluidic chamber or microfluidic channel.
67. The method of claim 58, wherein the microfluidic device is an organ-on-chip device or a Transwell device.
68. The method of claim 58, wherein the microfluidic device further includes ports in fluid communication with the top and bottom compartments and the seeding comprises introducing cells into the ports in a flow of culture media.
69. A method for restricting the position of cells in a microfluidic device, the device including a porous membrane, the porous membrane including i) pores and ii) first and second sides, the method comprising:
a) forming a gel in the first or second side of the membrane, or portion thereof; and b) seeding cells on a region of the membrane on the side opposite to the side comprising the gel under conditions such that the cells are prevented by the gel from moving through the pores, thereby restricting the position of the cells in the microfluidic device.
70. The method of claim 69, further comprising c) removing the gel from the microfluidic device.
71. The method of claim 69, wherein the gel is a water impermeable gel.
72. The method of claim 69, wherein the gel is a calcium alginate gel and the gel is removed by washing out or chelating the calcium in the calcium alginate gel.
73. The method of claim 58, wherein the microfluidic device is an organ-on-chip device or a Transwell device.
74. The method of claim 70, wherein the gel is a collagen gel and the collagen gel is removed with an enzyme.
PCT/US2016/064647 2015-12-04 2016-12-02 Devices, methods, and compositions for restricting cell position and stabilizing cells in culture systems Ceased WO2017116608A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA3007084A CA3007084A1 (en) 2015-12-04 2016-12-02 Devices, methods, and compositions for restricting cell position and stabilizing cells in culture systems
US15/781,080 US20200263118A1 (en) 2015-12-04 2016-12-02 Devices, Methods, And Compositions For Restricting Cell Position And Stabilizing Cells In Culture Systems
AU2016382614A AU2016382614A1 (en) 2015-12-04 2016-12-02 Devices, methods, and compositions for restricting cell position and stabilizing cells in culture systems
SG11201804575QA SG11201804575QA (en) 2015-12-04 2016-12-02 Devices, methods, and compositions for restricting cell position and stabilizing cells in culture systems
GB1810996.7A GB2562920B (en) 2015-12-04 2016-12-02 Devices, methods, and compositions for restricting cell position and stabilizing cells in culture systems

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562263383P 2015-12-04 2015-12-04
US62/263,383 2015-12-04
US201662333007P 2016-05-06 2016-05-06
US62/333,007 2016-05-06

Publications (2)

Publication Number Publication Date
WO2017116608A2 true WO2017116608A2 (en) 2017-07-06
WO2017116608A3 WO2017116608A3 (en) 2017-09-14

Family

ID=59227395

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2016/064647 Ceased WO2017116608A2 (en) 2015-12-04 2016-12-02 Devices, methods, and compositions for restricting cell position and stabilizing cells in culture systems

Country Status (6)

Country Link
US (1) US20200263118A1 (en)
AU (1) AU2016382614A1 (en)
CA (1) CA3007084A1 (en)
GB (2) GB2591709B (en)
SG (1) SG11201804575QA (en)
WO (1) WO2017116608A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107828655A (en) * 2017-11-15 2018-03-23 大连理工大学 A microfluidic chip and its application
US11498067B2 (en) 2020-10-23 2022-11-15 City University Of Hong Kong Apparatus and a method for patterning biological cells

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7251725B2 (en) * 2017-01-18 2023-04-04 伸晃化学株式会社 Device for chemical substance evaluation and chemical substance evaluation method
CN108424852B (en) * 2018-03-14 2021-04-27 张洪剑 Transwell cell culture device simulating stress effect of blood vessel wall
TWI708842B (en) * 2019-10-02 2020-11-01 中原大學 Bionic organ device and method for making the same
JP2023119434A (en) * 2022-02-16 2023-08-28 ウシオ電機株式会社 Microfluidic device and method of using the microfluidic device

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03218303A (en) * 1989-09-26 1991-09-25 Kirin Brewery Co Ltd Improved alginate gel beads
US5395613A (en) * 1990-05-25 1995-03-07 Scholl Plc Process for degradation of keratin, keratinaceous material, collagen and collagenaceous material with enzyme material, cell-free culture or cell culture from micrococcus sedentarius
DE69936212T2 (en) * 1998-09-04 2008-01-24 Scios Inc., Sunnyvale Controlled release hydrogel compositions for the administration of growth factors
US20030104347A1 (en) * 2000-03-21 2003-06-05 Yuichi Mori Coating material for living organism tissue, coated product from living organism tissue and method of coating living organism material
WO2003046129A2 (en) * 2001-11-09 2003-06-05 Trustees Of The University Of Pennsylvania Compositions for the derivation of germ cells from stem cells and methods of use thereof
CA2515213A1 (en) * 2003-02-11 2004-08-26 University Of Washington Stimuli-responsive polymer conjugates and related methods
US7851189B2 (en) * 2005-03-07 2010-12-14 Boston Scientific Scimed, Inc. Microencapsulated compositions for endoluminal tissue engineering
US20110081677A1 (en) * 2009-09-30 2011-04-07 University Of Maryland, College Park Active Microfluidic Membranes
WO2013067525A2 (en) * 2011-11-04 2013-05-10 President And Fellows Of Harvard College Self-regulating chemo-mechano-chemical systems
EP2788119A1 (en) * 2011-12-05 2014-10-15 Research Triangle Institute Human conducting airway model comprising multiple fluidic pathways
US9725687B2 (en) * 2011-12-09 2017-08-08 President And Fellows Of Harvard College Integrated human organ-on-chip microphysiological systems
SG11201600932XA (en) * 2013-08-07 2016-03-30 Agency Science Tech & Res Methods, apparatuses, and systems for cell and tissue culture
US10052283B2 (en) * 2014-02-20 2018-08-21 Gwangju Institute Of Science And Technology Composition for forming pluronic-based hydrogel with improved stability

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107828655A (en) * 2017-11-15 2018-03-23 大连理工大学 A microfluidic chip and its application
US11498067B2 (en) 2020-10-23 2022-11-15 City University Of Hong Kong Apparatus and a method for patterning biological cells

Also Published As

Publication number Publication date
GB2562920A (en) 2018-11-28
WO2017116608A3 (en) 2017-09-14
US20200263118A1 (en) 2020-08-20
GB2591709A (en) 2021-08-04
GB202106820D0 (en) 2021-06-30
GB2591709B (en) 2021-11-03
GB2562920B (en) 2021-06-30
SG11201804575QA (en) 2018-06-28
GB201810996D0 (en) 2018-08-15
CA3007084A1 (en) 2017-07-06
AU2016382614A1 (en) 2018-07-19

Similar Documents

Publication Publication Date Title
US20200263118A1 (en) Devices, Methods, And Compositions For Restricting Cell Position And Stabilizing Cells In Culture Systems
JP7186977B2 (en) Systems and methods for biomimetic fluid processing
US11396016B2 (en) System and method for a biomimetic fluid processing
US6897064B2 (en) Cell or tissue-culturing carrier, and culturing method
EP2404992A1 (en) Cell evaluation system using cell sheet and method for using same
EP1702052A1 (en) Cultured cell and method and apparatus for cell culture
JP7007267B2 (en) Improved method for tissue manufacturing
Wang et al. Microfluidic engineering of neural stem cell niches for fate determination
EP3077499A1 (en) Fluidic device and perfusion system for in vitro complex living tissue reconstruction
US20240200032A1 (en) Method for differentiation to stem cell derived hyaline cartilage spheroid and uses thereof
US20120094372A1 (en) Ex Vivo Cell Culture: Enabling Process and Devices
US20180291324A1 (en) Biomimetic amniotic membrane niche for stem cells
Mazzaglia Development of a hydrogel-based microfluidic model of the lymph node
WO2025188828A1 (en) Flexible fluidic percolated networks and uses thereof
CN120883055A (en) Hepatic vascular system
Marshall Microgels for In Vitro Three-Dimensional Cancer Models
Chan Microfluidics-generated Double Emulsion Platform for High-Throughput Screening and Multicellular Spheroid Production with Controllable Microenvironment
Mallaredy et al. Hydrogel-microfluidic devices for 3D cell culture
Mignone et al. A Simple, Cost-Effective Method to Improve Cell Viability in Microniche Culture Systems

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 11201804575Q

Country of ref document: SG

ENP Entry into the national phase

Ref document number: 3007084

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 201810996

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20161202

WWE Wipo information: entry into national phase

Ref document number: 1810996.7

Country of ref document: GB

ENP Entry into the national phase

Ref document number: 2016382614

Country of ref document: AU

Date of ref document: 20161202

Kind code of ref document: A

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16882263

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 16882263

Country of ref document: EP

Kind code of ref document: A2